Ovarian Cancer Market Size, Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight
DelveInsight’s “Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Ovarian Cancer, historical and forecasted epidemiology as well as the Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Ovarian cancer is a disease that affects women and is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.
Some key facts of Ovarian Cancer Market are:
- The rate of new cases of ovarian cancer was 11.2 per 100,000 women per year.
- The death rate was 6.7 per 100,000 women per year. These rates are age-adjusted and based on 2013–2017 cases and 2014–2018 deaths.
- Approximately 1.2 percent of women will be diagnosed with ovarian cancer at some point during their lifetime, based on 2015–2017 data.
- In 2017, there were an estimated 233,364 women living with ovarian cancer in the United States.
- The earlier ovarian cancer is caught, the better chance a person has of surviving five years after being diagnosed. For ovarian cancer, 15.7% are diagnosed at the local stage. The 5-year relative survival for localized ovarian cancer is 92.6%.
Request for free Sample Report: https://www.delveinsight.com/sample-request/ovarian-cancer-market
Scope of Ovarian Cancer Market are:
- The report covers the descriptive overview of Ovarian Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Ovarian Cancer epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Ovarian Cancer are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Ovarian Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Ovarian Cancer market
Ovarian Cancer Companies are:
- Celsion
- Oncology Venture
- ImmunoVaccine Technologies
- OncoQuest
- Harpoon Therapeutics
- Immunogen
- Shattuck Labs
- Precigen
- Roche
- Ellipses Pharma
- Artios Pharma
- And Many Others
Request for free Sample Report: https://www.delveinsight.com/sample-request/ovarian-cancer-market
Ovarian Cancer Therapies:
- GEN-1
- 2X-121
- PXSurvivac
- Oregovomab
- HPN536
- Mirvetuximab soravtansine (IMGN853)
- SL-172154
- PRGN-3005 UltraCAR-T
- Ipatasertib and Rucaparib combination
- EP0057
- ART0380
- And Many Others
DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.
About DelveInsight
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Know more about our competitive intelligence services.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/ovarian-cancer-market
